Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for cost of medicines
Fordham 2016: Will purposive construction of Swiss-type claims save second-medical use patents? Fordham 2016: Will purposive construction of Swiss-type claims save second-medical use patents? Reviewed by Annsley Merelle Ward on Tuesday, April 05, 2016 Rating: 5
Letter from AmeriKat: Will narrowing innovator-generic price gap change IP law? Letter from AmeriKat: Will narrowing innovator-generic price gap change IP law? Reviewed by Annsley Merelle Ward on Monday, March 16, 2015 Rating: 5
The ethics of biotech patenting: a dialogue about monopolies, human dignity and the cost of medicines The ethics of biotech patenting: a dialogue about monopolies, human dignity and the cost of medicines Reviewed by Suleman Ali on Sunday, January 11, 2015 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.